During the week of Feb. 25 - March 3, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:
The Food and Drug Administration debarred Adrian Vela from importing food or offering food for importation into the U.S. for five years. Vela was convicted in November 2011 in Southern Florida District Court for conspiracy to falsely label and misbrand food, one count of false labeling of seafood under the Lacey Act, and one count of misbranding food, FDA said. In 2008 and 2009, Vela imported shrimp from Thailand, Malaysia, and Indonesia, but directed a Tampa facility to repack and relabel the shrimp as a product of Panama in order to make it more readily marketable. The relabeled shrimp were then sold to a wholesaler in Keene, N.H., which in turn sold the shrimp to a supermarket chain headquartered in Landover, Md., FDA said (presumably the mid-Atlantic chain Giant Foods).
The Food and Drug Administration issued orders granting exemptions for premarket notification requirements for stairway chair lift (here) and inclined/vertical platform lift devices (here), subject to certain conditions. Effective March 4, these devices may be distributed without a letter of substantial equivalence from FDA. Conditions for the exemption include appropriate analysis and testing and restraints to prevent the user from falling.
On Feb. 27 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
During the week of Feb. 18-24, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:
The Food and Drug Administration issued its weekly Enforcement Report for Feb. 27 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.
The Food and Drug Administration issued its international food safety capacity-building plan, as required by the Food Safety Modernization Act. FSMA requires FDA to develop a plan to expand technical, scientific, and regulatory food safety capacity of foreign governments and food industries in countries that export food to the U.S.
On Feb. 26 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 25 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration will continue to target imported cantaloupes at the border for sampling after two major outbreaks in recent years, it said in a letter to the cantaloupe industry. The letter encouraged the cantaloupe industry to “observe best practices already recognized by FDA and the industry as effective in reducing the risk of harmful contamination,” it said. The outbreaks occurred in 2011 and 2012 as a result of unsanitary conditions at domestic cantaloupe packinghouses, FDA said, and were caused by the bacterial pathogens listeria monocytogenes and salmonella.